Alkermes plc. Operating Cash Flow
Alkermes plc. (ALKS) reported Operating Cash Flow of -$20.56 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-07-28.
Financial Statements › Cash Flow › Operating Activities
us-gaap:NetCashProvidedByUsedInOperatingActivities · last filed 2026-07-28
- Alkermes plc. net cash provided by (used in) operating activities for the quarter ending 2026-06-30 was $145.18M, a 3.34% decline year-over-year.
- Alkermes plc. net cash provided by (used in) operating activities for the quarter ending 2026-03-31 was -$165.74M, a 267.74% decline year-over-year.
- Alkermes plc. net cash provided by (used in) operating activities for the quarter ending 2025-12-31 was $170.07M, a 10.68% decline year-over-year.
- Alkermes plc. net cash provided by (used in) operating activities for the quarter ending 2025-09-30 was $101.67M, a 24.61% increase year-over-year.
- Alkermes plc. net cash provided by (used in) operating activities for fiscal 2025 was $520.75M, a 18.59% increase from fiscal 2024.
- Alkermes plc. net cash provided by (used in) operating activities for fiscal 2024 was $439.12M, a 9.41% increase from fiscal 2023.
- Alkermes plc. net cash provided by (used in) operating activities for fiscal 2023 was $401.35M, a 1807.21% increase from fiscal 2022.
- Alkermes plc. net cash provided by (used in) operating activities for fiscal 2022 was $21.04M, a 79.31% decline from fiscal 2021.
| Period end | Net Cash Provided by (Used in) Operating Activities 3 month | Net Cash Provided by (Used in) Operating Activities 6 month | Net Cash Provided by (Used in) Operating Activities 9 month | Net Cash Provided by (Used in) Operating Activities 12 month |
|---|---|---|---|---|
| 2026-06-30 | $145.18M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-28 | -$20.56M 10-Q · filed 2026-07-28 | $149.51M derived: sum of 3 quarters · filed 2026-07-28 | $251.18M derived: sum of 4 quarters · filed 2026-07-28 |
| 2026-03-31 | -$165.74M 10-Q · filed 2026-05-05 | $4.33M derived: sum of 2 quarters · filed 2026-05-05 | $106.00M derived: sum of 3 quarters · filed 2026-05-05 | $256.20M derived: sum of 4 quarters · filed 2026-07-28 |
| 2025-12-31 | $170.07M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $271.74M derived: sum of 2 quarters · filed 2026-02-25 | $421.94M derived: sum of 3 quarters · filed 2026-07-28 | $520.75M 10-K · filed 2026-02-25 |
| 2025-09-30 | $101.67M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-28 | $251.87M derived: sum of 2 quarters · filed 2026-07-28 | $350.69M 10-Q · filed 2025-10-28 | $541.08M derived: sum of 4 quarters · filed 2026-07-28 |
| 2025-06-30 | $150.20M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-28 | $249.01M 10-Q · filed 2026-07-28 | $439.41M derived: sum of 3 quarters · filed 2026-07-28 | $521.00M derived: sum of 4 quarters · filed 2026-07-28 |
| 2025-03-31 | $98.81M 10-Q · filed 2026-05-05 | $289.21M derived: sum of 2 quarters · filed 2026-05-05 | $370.80M derived: sum of 3 quarters · filed 2026-05-05 | $516.83M derived: sum of 4 quarters · filed 2026-05-05 |
| 2024-12-31 | $190.40M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $271.99M derived: sum of 2 quarters · filed 2026-02-25 | $418.02M derived: sum of 3 quarters · filed 2026-02-25 | $439.12M 10-K · filed 2026-02-25 |
| 2024-09-30 | $81.59M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-28 | $227.62M derived: sum of 2 quarters · filed 2025-10-28 | $248.73M 10-Q · filed 2025-10-28 | $355.96M derived: sum of 4 quarters · filed 2026-02-25 |
| 2024-06-30 | $146.03M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-29 | $167.14M 10-Q · filed 2025-07-29 | $274.38M derived: sum of 3 quarters · filed 2026-02-25 | $374.08M derived: sum of 4 quarters · filed 2026-02-25 |
| 2024-03-31 | $21.11M 10-Q · filed 2025-05-01 | $128.34M derived: sum of 2 quarters · filed 2026-02-25 | $228.05M derived: sum of 3 quarters · filed 2026-02-25 | $443.76M derived: sum of 4 quarters · filed 2026-02-25 |
| 2023-12-31 | $107.24M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $206.94M derived: sum of 2 quarters · filed 2026-02-25 | $422.65M derived: sum of 3 quarters · filed 2026-02-25 | $401.35M 10-K · filed 2026-02-25 |
| 2023-09-30 | $99.71M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-24 | $315.42M derived: sum of 2 quarters · filed 2024-10-24 | $294.12M 10-Q · filed 2024-10-24 | $295.16M derived: sum of 4 quarters · filed 2025-02-12 |
| 2023-06-30 | $215.71M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-07-24 | $194.41M 10-Q · filed 2024-07-24 | $195.46M derived: sum of 3 quarters · filed 2025-02-12 | $196.08M derived: sum of 4 quarters · filed 2025-02-12 |
| 2023-03-31 | -$21.30M 10-Q · filed 2024-05-01 | -$20.25M derived: sum of 2 quarters · filed 2025-02-12 | -$19.63M derived: sum of 3 quarters · filed 2025-02-12 | -$21.94M derived: sum of 4 quarters · filed 2025-02-12 |
| 2022-12-31 | $1.05M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-12 | $1.67M derived: sum of 2 quarters · filed 2025-02-12 | -$634.00K derived: sum of 3 quarters · filed 2025-02-12 | $21.04M 10-K · filed 2025-02-12 |
| 2022-09-30 | $625.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-10-25 | -$1.68M derived: sum of 2 quarters · filed 2023-10-25 | $20.00M 10-Q · filed 2023-10-25 | $51.02M derived: sum of 4 quarters · filed 2024-02-21 |
| 2022-06-30 | -$2.31M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-07-26 | $19.37M 10-Q · filed 2023-07-26 | $50.39M derived: sum of 3 quarters · filed 2024-02-21 | $133.17M derived: sum of 4 quarters · filed 2024-02-21 |
| 2022-03-31 | $21.68M 10-Q · filed 2023-04-26 | $52.70M derived: sum of 2 quarters · filed 2024-02-21 | $135.48M derived: sum of 3 quarters · filed 2024-02-21 | $168.54M derived: sum of 4 quarters · filed 2024-02-21 |
| 2021-12-31 | $31.02M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-21 | $113.80M derived: sum of 2 quarters · filed 2024-02-21 | $146.86M derived: sum of 3 quarters · filed 2024-02-21 | $101.72M 10-K · filed 2024-02-21 |
| 2021-09-30 | $82.78M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-02 | $115.84M derived: sum of 2 quarters · filed 2022-11-02 | $70.69M 10-Q · filed 2022-11-02 | $138.04M derived: sum of 4 quarters · filed 2023-02-16 |
| 2021-06-30 | $33.06M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-07-27 | -$12.08M 10-Q · filed 2022-07-27 | $55.26M derived: sum of 3 quarters · filed 2023-02-16 | $115.46M derived: sum of 4 quarters · filed 2023-02-16 |
| 2021-03-31 | -$45.15M 10-Q · filed 2022-04-27 | $22.20M derived: sum of 2 quarters · filed 2023-02-16 | $82.40M derived: sum of 3 quarters · filed 2023-02-16 | $77.97M derived: sum of 4 quarters · filed 2023-02-16 |
| 2020-12-31 | $67.34M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-16 | $127.55M derived: sum of 2 quarters · filed 2023-02-16 | $123.11M derived: sum of 3 quarters · filed 2023-02-16 | $82.84M 10-K · filed 2023-02-16 |
| 2020-09-30 | $60.20M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-10-27 | $55.77M derived: sum of 2 quarters · filed 2021-10-27 | $15.50M 10-Q · filed 2021-10-27 | $57.57M derived: sum of 4 quarters · filed 2022-02-16 |
| 2020-06-30 | -$4.43M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-07-28 | -$44.70M 10-Q · filed 2021-07-28 | -$2.63M derived: sum of 3 quarters · filed 2022-02-16 | $28.34M derived: sum of 4 quarters · filed 2022-02-16 |
| 2020-03-31 | -$40.27M 10-Q · filed 2021-04-28 | $1.80M derived: sum of 2 quarters · filed 2022-02-16 | $32.77M derived: sum of 3 quarters · filed 2022-02-16 | $9.59M derived: sum of 4 quarters · filed 2022-02-16 |
| 2019-12-31 | $42.07M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-16 | $73.04M derived: sum of 2 quarters · filed 2022-02-16 | $49.87M derived: sum of 3 quarters · filed 2022-02-16 | $72.08M 10-K · filed 2022-02-16 |
| 2019-09-30 | $30.97M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-10-29 | $7.79M derived: sum of 2 quarters · filed 2020-10-29 | $30.01M 10-Q · filed 2020-10-29 | $90.52M derived: sum of 4 quarters · filed 2021-02-11 |
| 2019-06-30 | -$23.18M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-29 | -$965.00K 10-Q · filed 2020-07-29 | $59.55M derived: sum of 3 quarters · filed 2021-02-11 | $93.03M derived: sum of 4 quarters · filed 2021-02-11 |
| 2019-03-31 | $22.21M 10-Q · filed 2020-04-29 | $82.72M derived: sum of 2 quarters · filed 2021-02-11 | $116.20M derived: sum of 3 quarters · filed 2021-02-11 | $148.33M derived: sum of 4 quarters · filed 2021-02-11 |
| 2018-12-31 | $60.51M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-11 | $93.99M derived: sum of 2 quarters · filed 2021-02-11 | $126.12M derived: sum of 3 quarters · filed 2021-02-11 | $99.28M 10-K · filed 2021-02-11 |
| 2018-09-30 | $33.48M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-23 | $65.61M derived: sum of 2 quarters · filed 2019-10-23 | $38.77M 10-Q · filed 2019-10-23 | $74.68M derived: sum of 4 quarters · filed 2020-02-13 |
| 2018-06-30 | $32.13M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-07-25 | $5.29M 10-Q · filed 2019-07-25 | $41.20M derived: sum of 3 quarters · filed 2020-02-13 | $60.68M derived: sum of 4 quarters · filed 2020-02-13 |
| 2018-03-31 | -$26.84M 10-Q · filed 2019-04-25 | $9.07M derived: sum of 2 quarters · filed 2020-02-13 | $28.55M derived: sum of 3 quarters · filed 2020-02-13 | $6.10M derived: sum of 4 quarters · filed 2020-02-13 |
| 2017-12-31 | $35.91M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-13 | $55.39M derived: sum of 2 quarters · filed 2020-02-13 | $32.94M derived: sum of 3 quarters · filed 2020-02-13 | $19.19M 10-K · filed 2020-02-13 |
| 2017-09-30 | $19.48M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-10-23 | -$2.97M derived: sum of 2 quarters · filed 2018-10-23 | -$16.72M 10-Q · filed 2018-10-23 | -$9.16M derived: sum of 4 quarters · filed 2019-02-15 |
| 2017-06-30 | -$22.45M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-07-26 | -$36.20M 10-Q · filed 2018-07-26 | -$28.64M derived: sum of 3 quarters · filed 2019-02-15 | -$13.91M derived: sum of 4 quarters · filed 2019-02-15 |
| 2017-03-31 | -$13.75M 10-Q · filed 2018-04-26 | -$6.19M derived: sum of 2 quarters · filed 2019-02-15 | $8.54M derived: sum of 3 quarters · filed 2019-02-15 | |
| 2016-12-31 | $7.56M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-15 | $22.29M derived: sum of 2 quarters · filed 2019-02-15 | -$63.80M 10-K · filed 2019-02-15 | |
| 2016-09-30 | $14.73M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-10-26 | -$71.36M 10-Q · filed 2017-10-26 | ||
| 2016-06-30 | -$86.09M 10-Q · filed 2017-07-27 | |||
| 2015-12-31 | -$40.36M 10-K · filed 2018-02-16 | |||
| 2012-03-31 | $15.28M derived: 10-K 12 month − 10-Q 9 month · filed 2012-05-18 | $13.07M derived: sum of 2 quarters · filed 2012-05-18 | -$2.48M 10-K · filed 2012-05-18 | |
| 2011-12-31 | -$2.21M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-02-02 | -$17.76M 10-Q · filed 2012-02-02 | ||
| 2011-09-30 | -$15.55M 10-Q · filed 2011-11-03 | |||
| 2011-03-31 | $8.27M derived: 10-K 12 month − 10-Q 9 month · filed 2012-05-18 | $21.17M derived: sum of 2 quarters · filed 2012-05-18 | -$5.91M 10-K · filed 2012-05-18 | |
| 2010-12-31 | $12.90M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-02-02 | -$14.18M 10-Q · filed 2012-02-02 | ||
| 2010-09-30 | -$27.08M 10-Q · filed 2011-11-03 | |||
| 2010-03-31 | -$12.25M 10-K · filed 2012-05-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| RHYTHM PHARMACEUTICALS, INC. (RYTM) | United States | $6.771B | -37.20 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |
| Amneal Pharmaceuticals, Inc. (AMRX) | $6.326B | 25.62 | |
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| Travere Therapeutics, Inc. (TVTX) | United States | $5.712B | -123.10 |
| Oruka Therapeutics, Inc. (ORKA) | United States | $5.663B | -43.76 |